Kingmed Diagnostics

Forecast & Rating7 analysts currently cover Kingmed Diagnostics, with about 57.1% giving a positive rating — meaning they expect the stock to rise. The average price target is ¥30.90, about 10.5% upside from the current price of ¥27.96. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 16.2% of past price targets were eventually met, which adds credibility. For you, this means institutional views on Kingmed Diagnostics are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Aug 4, 2026; for reference only and not investment advice.